
  Mrv1909 05201914422D          

  1  0  0  0  0  0            999 V2000
    0.0000    0.0000    0.0000 Pd  0  0  0  0  0  0  0  0  0  0  0  0
M  ISO  1   1 103
M  END
> <DATABASE_ID>
DB15016

> <DATABASE_NAME>
drugbank

> <SMILES>
[103Pd]

> <INCHI_IDENTIFIER>
InChI=1S/Pd/i1-3

> <INCHI_KEY>
KDLHZDBZIXYQEI-OIOBTWANSA-N

> <FORMULA>
Pd

> <MOLECULAR_WEIGHT>
102.9061

> <EXACT_MASS>
102.906087204

> <JCHEM_ACCEPTOR_COUNT>
0

> <JCHEM_ATOM_COUNT>
1

> <JCHEM_AVERAGE_POLARIZABILITY>
1.7784

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
0

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
(103Pd)palladium

> <JCHEM_LOGP>
0.0

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
0

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_POLAR_SURFACE_AREA>
0.0

> <JCHEM_REFRACTIVITY>
0.0

> <JCHEM_ROTATABLE_BOND_COUNT>
0

> <JCHEM_RULE_OF_FIVE>
1

> <JCHEM_TRADITIONAL_IUPAC>
(2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.0^{2,6}.0^{8,18}.0^{12,17}]nonadeca-1(18),8,12(17),13,15-pentaen-11-one

> <JCHEM_VEBER_RULE>
1

> <DRUGBANK_ID>
DB15016

> <DRUG_GROUPS>
investigational

> <GENERIC_NAME>
Palladium Pd-103

$$$$
